CN1333779A - 用作平滑肌细胞增殖抑制剂的苄基乳糖酸酰胺 - Google Patents

用作平滑肌细胞增殖抑制剂的苄基乳糖酸酰胺 Download PDF

Info

Publication number
CN1333779A
CN1333779A CN99813573A CN99813573A CN1333779A CN 1333779 A CN1333779 A CN 1333779A CN 99813573 A CN99813573 A CN 99813573A CN 99813573 A CN99813573 A CN 99813573A CN 1333779 A CN1333779 A CN 1333779A
Authority
CN
China
Prior art keywords
carbon atom
acyl group
acid
hydrogen
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99813573A
Other languages
English (en)
Chinese (zh)
Inventor
S·C·马耶尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of CN1333779A publication Critical patent/CN1333779A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN99813573A 1998-11-24 1999-11-23 用作平滑肌细胞增殖抑制剂的苄基乳糖酸酰胺 Pending CN1333779A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19898298A 1998-11-24 1998-11-24
US09/198,982 1998-11-24

Publications (1)

Publication Number Publication Date
CN1333779A true CN1333779A (zh) 2002-01-30

Family

ID=22735720

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99813573A Pending CN1333779A (zh) 1998-11-24 1999-11-23 用作平滑肌细胞增殖抑制剂的苄基乳糖酸酰胺

Country Status (7)

Country Link
EP (1) EP1133507A2 (fr)
JP (1) JP2002530417A (fr)
CN (1) CN1333779A (fr)
AU (1) AU5706699A (fr)
BR (1) BR9915641A (fr)
CA (1) CA2351061A1 (fr)
WO (1) WO2000031092A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2308536T3 (es) * 2004-08-05 2008-12-01 Ivax Drug Research Institute Ltd Glicosidos polisulfatados y sales de los mismos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
IL115745A (en) * 1994-11-07 2000-11-21 American Home Prod Acylated benzylglycosides and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP1133507A2 (fr) 2001-09-19
JP2002530417A (ja) 2002-09-17
AU5706699A (en) 2000-06-13
WO2000031092A2 (fr) 2000-06-02
WO2000031092A3 (fr) 2001-01-18
CA2351061A1 (fr) 2000-06-02
BR9915641A (pt) 2001-08-07

Similar Documents

Publication Publication Date Title
JP2745351B2 (ja) ペプチド誘導体及びその用途
CN102858790A (zh) 核苷氨基磷酸酯
CN101817769B (zh) 脲基类肽氨肽酶n抑制剂及其应用
CA2771056A1 (fr) Octasaccharides n-acyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
CN1333779A (zh) 用作平滑肌细胞增殖抑制剂的苄基乳糖酸酰胺
CN1191264C (zh) 作为抗生素的尿苷衍生物
CN1205742A (zh) N－乙酰基－(L)－4－氰基苯丙氨酸Ac(L)Phe(4－CN)－OH与N－乙酰基－(L)－对脒基苯丙氨酸－环己基甘氨酸β－(3－N甲基吡啶鎓)－丙氨酸Ac(L)-PAph－Chg-PalMe(3)－NH2的新颖的制备方法
CN1329616A (zh) 用作平滑肌细胞增殖抑制剂的酰化的苄基麦芽糖苷
US6664243B1 (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US7081448B2 (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
CN1046512C (zh) 巯基乙酰胺二硫化物衍生物，其制备方法及含有它们的药物组合物
CN1333780A (zh) 用作平滑肌细胞增殖抑制剂的苄基糖基酰胺
CN1333784A (zh) 用作平滑肌细胞增殖抑制剂的苄基麦芽糖苷
JP5438998B2 (ja) 新規糖鎖プライマーとその利用
CN1333778A (zh) 用作平滑肌细胞增殖抑制剂的苄基麦芽三糖苷
CN1333781A (zh) 用作平滑肌细胞增生抑制剂的苄基糖酰胺
FR2970969A1 (fr) Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
US6451767B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
US6291434B1 (en) Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
MXPA01005175A (en) Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
US6362170B1 (en) Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
WO2008023796A1 (fr) Promoteur de la production de protéoglycane
JP6051211B2 (ja) 半減期が短く活性が高い合成五糖類
TW202005977A (zh) 阿伐-選擇性唾液酸供體及其於製備唾液酸苷的用途
JP2004256433A (ja) ガラクトース二硫酸誘導体

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication